Journal of Clinical Endocrinology & Metabolism, Vol 75, 756-761, Copyright © 1992 by Endocrine Society

ARTICLES

Activin-A inhibits progesterone production by macaque luteal cells in culture

JD Brannian, TK Woodruff, JP Mather and RL Stouffer
Division of Reproductive Biology and Behavior, Oregon Regional Primate Research Center, Beaverton 97006.

Since inhibin is produced during the luteal phase of the menstrual cycle in women and nonhuman primates, the primate corpus luteum (CL) may be a local site of inhibin/activin action. This study was designed to determine whether inhibin or activin altered steroidogenesis by macaque luteal cells in vitro. Luteal cells were obtained by enzymatic dispersion of CL from rhesus monkeys at midluteal phase of the menstrual cycle. Cells (2 x 10(4)/0.2 mL) were cultured in wells coated with extracellular matrix from bovine corneal endothelial cells in Dulbecco's modified Eagle's medium/F-12 medium (1:1 vol/vol) + insulin (2 ng/mL), transferrin (5 ng/mL), H2SeO3 (0.25 nmol), and aprotinin (10 micrograms/mL). Various concentrations (0-400 ng/mL) of recombinant human-inhibin-A, recombinant human-activin-A or human CG (hCG) (100 ng/mL; CR123) alone or in combination with inhibin or activin were added to the culture media (n = 5 Exp). Media were changed daily for 4 days and progesterone (P) concentrations were determined by RIA. Inhibin exposure did not alter P levels compared to that of control (untreated) cultures. In contrast, activin (10-400 ng/mL) suppressed P production (P less than 0.05) below controls and inhibin-treated cultures by days 3 and 4. Exposure to hCG increased P levels throughout culture (9 x control levels by day 4; P less than 0.05). hCG-stimulated P production was unaltered by inhibin, whereas activin (50-400 ng/mL) reduced (maximal inhibition of 40%; P less than 0.05) hCG-stimulated P production by day 4 of culture. Cell number on day 4 was not altered by any dose of inhibin or activin, but the number of cells staining for 3 beta-hydroxysteroid dehydrogenase was reduced (P less than 0.05) by 32.9 +/- 2.6% in activin-treated cultures. Since P levels declined during culture in all treatment groups, in a second series of experiments (n = 4), luteal cells were cultured for 4 days with or without hCG (100 ng/mL) and low density lipoprotein (LDL; 100 micrograms/mL) +/- 0-400 ng activin/mL. P production in the presence of hCG+LDL was greatly enhanced compared to other treatment groups and was sustained during days 2-4 of culture. Activin at doses of 50-400 ng/mL suppressed (maximal inhibition of approximately 35%; P less than 0.05) hCG+LDL-stimulated P production on days 3 and 4. These results suggest that the primate CL is a target for activin action to suppress luteal cell activities, including gonadotropin-regulated, lipoprotein-mediated steroidogenesis.

This article has been cited by other articles:

				R. E. Dickinson, A. J. Stewart, M. Myers, R. P. Millar, and W. C. Duncan Differential Expression and Functional Characterization of Luteinizing Hormone Receptor Splice Variants in Human Luteal Cells: Implications for Luteolysis Endocrinology, June 1, 2009; 150(6): 2873 - 2881. [Abstract] [Full Text] [PDF]

				A. R Kayani, C. Glister, and P. G Knight Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle Reproduction, January 1, 2009; 137(1): 67 - 78. [Abstract] [Full Text] [PDF]

				M. Myers, S. van den Driesche, A. S McNeilly, and W C. Duncan Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro J. Endocrinol., November 1, 2008; 199(2): 201 - 212. [Abstract] [Full Text] [PDF]

				S. A. Pangas, C. J. Jorgez, M. Tran, J. Agno, X. Li, C. W. Brown, T. R. Kumar, and M. M. Matzuk Intraovarian Activins Are Required for Female Fertility Mol. Endocrinol., October 1, 2007; 21(10): 2458 - 2471. [Abstract] [Full Text] [PDF]

				P. G Knight and C. Glister TGF-{beta} superfamily members and ovarian follicle development. Reproduction, August 1, 2006; 132(2): 191 - 206. [Abstract] [Full Text] [PDF]

				N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]

				K. Y Arai, H. Kishi, S. Onodera, W. Jin, G. Watanabe, A. K Suzuki, S. Takahashi, T. Kamada, T. Nishiyama, and K. Taya Cyclic changes in messenger RNAs encoding inhibin/activin subunits in the ovary of the golden hamster (Mesocricetus auratus) J. Endocrinol., June 1, 2005; 185(3): 561 - 575. [Abstract] [Full Text] [PDF]

				J R V Silva, R van den Hurk, H T A van Tol, B A J Roelen, and J R Figueiredo Gene expression and protein localisation for activin-A, follistatin and activin receptors in goat ovaries J. Endocrinol., November 1, 2004; 183(2): 405 - 415. [Abstract] [Full Text] [PDF]

				N. A. Cataldo, V. Y. Fujimoto, and R. B. Jaffe Interferon-{gamma} and Activin A Promote Insulin-Like Growth Factor-Binding Protein-2 and -4 Accumulation by Human Luteinizing Granulosa Cells, and Interferon-{gamma} Promotes Their Apoptosis J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 179 - 186. [Abstract] [Full Text]